Society of Pain and Palliative Care Pharmacists White Paper on the Role of Opioid Stewardship Pharmacists.

Sandra DiScala, Tanya J Uritsky, Michelle E Brown, Stephanie M Abel, Nicole T Humbert, Dharma Naidu
{"title":"Society of Pain and Palliative Care Pharmacists White Paper on the Role of Opioid Stewardship Pharmacists.","authors":"Sandra DiScala,&nbsp;Tanya J Uritsky,&nbsp;Michelle E Brown,&nbsp;Stephanie M Abel,&nbsp;Nicole T Humbert,&nbsp;Dharma Naidu","doi":"10.1080/15360288.2022.2149670","DOIUrl":null,"url":null,"abstract":"<p><p>Opioid stewardship is one essential function of pain and palliative care pharmacists and a critical need in the United States. In recent years, this country has been plagued by two public health emergencies: an opioid crisis and the COVID-19 pandemic, which has exacerbated the opioid epidemic through its economic and psychosocial toll. To develop an opioid stewardship program, a systematic approach is needed. This will be detailed in part here by the Opioid Stewardship Taskforce of the Society of Pain and Palliative Care Pharmacists (SPPCP), focusing on the role of the pharmacist. Many pain and palliative care pharmacists have made significant contributions to the development and daily operation of such programs while also completing other competing clinical tasks, including direct patient care. To ensure dedicated time and attention to critical opioid stewardship efforts, SPPCP recommends and endorses opioid stewardship models employing a full time, opioid stewardship pharmacist in both the inpatient and outpatient setting. Early research suggests that opioid stewardship pharmacists are pivotal to improving opioid metrics and pain care outcomes. However, further research and development in this area of practice is needed and encouraged.</p>","PeriodicalId":16645,"journal":{"name":"Journal of Pain & Palliative Care Pharmacotherapy","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pain & Palliative Care Pharmacotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15360288.2022.2149670","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Opioid stewardship is one essential function of pain and palliative care pharmacists and a critical need in the United States. In recent years, this country has been plagued by two public health emergencies: an opioid crisis and the COVID-19 pandemic, which has exacerbated the opioid epidemic through its economic and psychosocial toll. To develop an opioid stewardship program, a systematic approach is needed. This will be detailed in part here by the Opioid Stewardship Taskforce of the Society of Pain and Palliative Care Pharmacists (SPPCP), focusing on the role of the pharmacist. Many pain and palliative care pharmacists have made significant contributions to the development and daily operation of such programs while also completing other competing clinical tasks, including direct patient care. To ensure dedicated time and attention to critical opioid stewardship efforts, SPPCP recommends and endorses opioid stewardship models employing a full time, opioid stewardship pharmacist in both the inpatient and outpatient setting. Early research suggests that opioid stewardship pharmacists are pivotal to improving opioid metrics and pain care outcomes. However, further research and development in this area of practice is needed and encouraged.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
疼痛与姑息治疗药剂师协会阿片类药物管理药剂师的角色白皮书。
阿片类药物管理是疼痛和姑息治疗药剂师的一项基本功能,也是美国的一项关键需求。近年来,该国一直受到两起突发公共卫生事件的困扰:阿片类药物危机和COVID-19大流行,后者通过其经济和社会心理代价加剧了阿片类药物的流行。为了制定阿片类药物管理计划,需要一种系统的方法。这将由疼痛和姑息治疗药剂师协会(SPPCP)的阿片类药物管理工作组在这里部分详细说明,重点是药剂师的作用。许多疼痛和姑息治疗药剂师在完成其他竞争性临床任务(包括直接患者护理)的同时,对这些项目的发展和日常运作做出了重大贡献。为了确保对关键的阿片类药物管理工作投入时间和精力,SPPCP建议并支持在住院和门诊环境中雇用全职阿片类药物管理药剂师的阿片类药物管理模式。早期研究表明,阿片类药物管理药剂师对改善阿片类药物指标和疼痛护理结果至关重要。然而,需要并鼓励在这一实践领域进行进一步的研究和开发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.60
自引率
9.10%
发文量
40
期刊最新文献
Editorial: Reasons for Conflicting Evidence Regarding Use of Platelet-Rich Plasma (PRP). The Effectiveness of Tramadol in Pain Relief in Chronic Diseases: A Review Based on Clinical Trials. Changes in Pain and Mental Health Symptoms Associated with Prescribed Medicinal Cannabis Use: A One-Year Longitudinal Study. Correction. Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1